
Canada grants new patent for Rhelion's natural psilocybin drug PEX010, expanding its global patent portfolio.
Rhelion Life Sciences, through its subsidiary Filament Health, received a new Canadian patent for its natural psilocybin drug candidate PEX010. This patent enhances the company's extensive global intellectual property portfolio, which covers extracti...





